VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neuroreparative therapeutics, announced the appointment of Randall Kaye, MD, to the role of… Read More
New offering delivers convenient, comprehensive lab testing solutions for functional medicine, integrative medicine and primary care providers BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive… Read More
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with… Read More
UBC Faculty of Medicine researchers have been awarded more than $6.5 million from Brain Canada’s Platform Support Grants program to support two innovative neuroscience research platforms. The funding will help… Read More
Debiopharm taps ViewsML’s AI-driven platform to streamline biomarker detection in oncology research. VANCOUVER, BC – ViewsML, a techbio company specializing in AI-driven virtual staining and biomarkers for precision medicine and diagnostics, has announced… Read More
